Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0D2CU
|
||||
| Former ID |
DNC013625
|
||||
| Drug Name |
(R)-(-)-2-Methyl-apomorphine hydrochloride
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529328] | ||
| Formula |
C18H20ClNO2
|
||||
| Canonical SMILES |
CC1=CC2=C3C(CC4=C(C3=C1)C(=C(C=C4)O)O)N(CC2)C.Cl
|
||||
| InChI |
1S/C18H19NO2.ClH/c1-10-7-12-5-6-19(2)14-9-11-3-4-15(20)18(21)17(11)13(8-10)16(12)14;/h3-4,7-8,14,20-21H,5-6,9H2,1-2H3;1H/t14-;/m1./s1
|
||||
| InChIKey |
ZSVOQLKAAOSCNE-PFEQFJNWSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [529328] | |
| D(3) dopamine receptor | Target Info | Inhibitor | [529328] | ||
| WikiPathways | Hypothetical Network for Drug Addiction | ||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Genes and (Common) Pathways Underlying Drug Addiction | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| Nicotine Activity on Dopaminergic NeuronsWP58:Monoamine GPCRs | |||||
| Nicotine Activity on Dopaminergic Neurons | |||||
| GPCRs, Other | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.